-
公开(公告)号:US11834401B2
公开(公告)日:2023-12-05
申请号:US16921318
申请日:2020-07-06
IPC分类号: C07C49/825 , A61P35/00 , A61K31/12 , A61K31/136 , A61K31/15 , A61K31/27 , A61K45/06 , C07C271/58 , C07C275/30 , C12Q1/25 , C12Q1/02 , C07C251/80
CPC分类号: C07C49/825 , A61K31/12 , A61K31/136 , A61K31/15 , A61K31/27 , A61K45/06 , A61P35/00 , C07C251/80 , C07C271/58 , C07C275/30 , C12Q1/025 , G01N2333/44 , G01N2333/4712 , G01N2500/10 , A61K31/136 , A61K2300/00 , A61K31/12 , A61K2300/00 , A61K31/15 , A61K2300/00 , A61K31/27 , A61K2300/00
摘要: Described are methods of treating or preventing a disease in a subject treatable by modulating cell mechanics. The method includes administering to a subject having or at risk for such a disease a pharmaceutical composition. comprising an agent selected from the group comprising a salt, solvate, or stereoisomer of compound (VIII) or its derivatives or a mixture of their constituents, where the compound has the formula:
-
公开(公告)号:US10787410B2
公开(公告)日:2020-09-29
申请号:US15946849
申请日:2018-04-06
IPC分类号: A61K45/06 , A61K31/136 , A61K31/27 , A61K31/12 , A61K31/15 , A61P35/00 , C07C49/825 , C07C271/58 , C07C251/80 , C12Q1/02 , C07C275/30
摘要: Described are methods of treating or preventing a disease in a subject treatable by modulating cell mechanics. The method includes administering to a subject having or at risk for such a disease a pharmaceutical composition comprising an agent selected from the group comprising a salt, solvate, or stereoisomer of compound (VIII) or its derivatives or a mixture of their constituents, where the compound has the formula:
-
公开(公告)号:US20190062248A1
公开(公告)日:2019-02-28
申请号:US15946849
申请日:2018-04-06
IPC分类号: C07C49/825 , A61K45/06 , A61K31/136 , A61P35/00 , C12Q1/02 , C07C271/58 , A61K31/27 , A61K31/12 , C07C251/80 , A61K31/15
摘要: Described are methods of treating or preventing a disease in a subject treatable by modulating cell mechanics. The method includes administering to a subject having or at risk for such a disease a pharmaceutical composition. comprising an agent selected from the group comprising a salt, solvate, or stereoisomer of compound (VIII) or its derivatives or a mixture of their constituents, where the compound has the formula:
-
-